CN102532079B - Preparation method of Corey Lactone 3-benzoate - Google Patents
Preparation method of Corey Lactone 3-benzoate Download PDFInfo
- Publication number
- CN102532079B CN102532079B CN201110452240.1A CN201110452240A CN102532079B CN 102532079 B CN102532079 B CN 102532079B CN 201110452240 A CN201110452240 A CN 201110452240A CN 102532079 B CN102532079 B CN 102532079B
- Authority
- CN
- China
- Prior art keywords
- solvent
- lactone
- preparation
- coli
- dibenzoate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000002596 lactones Chemical class 0.000 title claims abstract description 103
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 17
- 238000006480 benzoylation reaction Methods 0.000 claims abstract description 16
- 230000002378 acidificating effect Effects 0.000 claims abstract description 13
- 238000005809 transesterification reaction Methods 0.000 claims abstract description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 54
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 51
- 239000002904 solvent Substances 0.000 claims description 49
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 39
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 29
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 20
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 16
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 15
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 14
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical group CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 12
- 239000002585 base Substances 0.000 claims description 12
- 239000003054 catalyst Substances 0.000 claims description 12
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical group C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 8
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 7
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 4
- HWWYDZCSSYKIAD-UHFFFAOYSA-N 3,5-dimethylpyridine Chemical compound CC1=CN=CC(C)=C1 HWWYDZCSSYKIAD-UHFFFAOYSA-N 0.000 claims description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000010410 layer Substances 0.000 claims description 2
- 239000012044 organic layer Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 238000005554 pickling Methods 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- -1 benzoyl core lactone Chemical class 0.000 abstract description 25
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- 125000006239 protecting group Chemical group 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000013375 chromatographic separation Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 238000003756 stirring Methods 0.000 description 18
- 239000012074 organic phase Substances 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 238000004064 recycling Methods 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000012452 mother liquor Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical group [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical group [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000000967 suction filtration Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HXUIDZOMTRMIOE-UHFFFAOYSA-N 3-oxo-3-phenylpropionic acid Chemical compound OC(=O)CC(=O)C1=CC=CC=C1 HXUIDZOMTRMIOE-UHFFFAOYSA-N 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical group [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Chemical group 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- RHFUXPCCELGMFC-UHFFFAOYSA-N n-(6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl)-n-phenylmethoxyacetamide Chemical compound OC1C(C)(C)OC2=CC=C(C#N)C=C2C1N(C(=O)C)OCC1=CC=CC=C1 RHFUXPCCELGMFC-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 229950009195 phenylpropanol Drugs 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- QYHFIVBSNOWOCQ-UHFFFAOYSA-N selenic acid Chemical compound O[Se](O)(=O)=O QYHFIVBSNOWOCQ-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供了一种苯甲酰科里内酯的制备方法。从科里内酯出发,通过苯甲酰化反应得到科里内酯二苯甲酸酯,然后创新性地利用酸性条件下的酯交换反应,选择性脱掉一个苯甲酰基得到产品。本发明提供的方法操作简单,无须使用昂贵的保护基,后期无须色谱分离,反应条件温和,产品收率高、纯度好、生产成本低,具有很好的工业化前景。
The invention provides a preparation method of benzoyl core lactone. Starting from Cory lactone, obtain Cory lactone dibenzoate through benzoylation reaction, and then creatively use the transesterification reaction under acidic conditions to selectively remove a benzoyl group to obtain the product. The method provided by the invention is simple to operate, does not need to use expensive protective groups, does not need chromatographic separation in the later stage, has mild reaction conditions, high product yield, good purity, low production cost, and has good industrialization prospects.
Description
技术领域 technical field
本发明涉及苯甲酰科里内酯的制备方法。 The invention relates to a preparation method of benzoyl core lactone. the
背景技术 Background technique
苯甲酰科里内酯代表(-)苯甲酰科里内酯或其对映异构体(+)苯甲酰科里内酯或外消旋体(±)苯甲酰科里内酯。其中(-)苯甲酰科里内酯全名为(3aR,4S,5R,6aS)-(-)-5-苯甲酰氧基-六氢-4-羟甲基-2H-环戊并[b]呋喃-2-酮((3aR,4S,5R,6aS)-4-hydroxymethyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate);分子式:C15H16O5;分子量:276.28;CAS No.:39746-00-4;其结构如下: Benzoyl lactone stands for (-) benzoyl lactone or its enantiomer (+) benzoyl lactone or racemate (±) benzoyl lactone . The full name of (-) benzoyl core lactone is (3aR, 4S, 5R, 6aS)-(-)-5-benzoyloxy-hexahydro-4-hydroxymethyl-2H-cyclopenta [b]furan-2-one ((3aR,4S,5R,6aS)-4-hydroxymethyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate); molecular formula: C 15 H 16 O 5 ; Molecular weight: 276.28; CAS No.: 39746-00-4; its structure is as follows:
(+)苯甲酰科里内酯全名为(3aS,4R,5S,6aR)-(+)-5-苯甲酰氧基-六氢-4-羟甲基-2H-环戊并[b]呋喃-2-酮((3aS,4R,5S,6aR)-4-hydroxymethyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate);分子式:C15H16O5;分子量:276.28;CAS:53275-53-9;其结构如下: The full name of (+) benzoyl core lactone is (3aS, 4R, 5S, 6aR)-(+)-5-benzoyloxy-hexahydro-4-hydroxymethyl-2H-cyclopenta[ b] furan-2-one ((3aS,4R,5S,6aR)-4-hydroxymethyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate); molecular formula: C 15 H 16 O 5 ; molecular weight : 276.28; CAS: 53275-53-9; its structure is as follows:
苯甲酰科里内酯是PG类药物重要的中间体,但对它们合成的直接文献报导却很少。文献Nature Chemical Biology2009,26-28从甲基化的衍生物脱甲基得到苯甲酰科里内酯;专利US6353000和US6353014从相应的醛还原得到苯甲酰科里内酯。上述两种方法中所用原料不易得到,成本较高,不适于工业化生产。 Benzoylcolides are important intermediates of PG drugs, but there are few direct literature reports on their synthesis. The literature Nature Chemical Biology2009, 26-28 obtains benzoyl corylide from the demethylation of the methylated derivative; patents US6353000 and US6353014 obtain benzoyl corylide from the reduction of the corresponding aldehyde. The raw materials used in the above two methods are not easy to obtain, the cost is relatively high, and they are not suitable for industrialized production. the
还有一种方法是以科里内脂为原料,选择性地在仲羟基上引入苯甲酰基,合成目标产物。科里内脂是一种常见的中间体,它很容易得到(Tetrahedron letters1976,4639-4642),所以由科里内脂制备苯甲酰科里内酯是比较实用的路线。目前比较典型的做法是:用一个大位阻的保护基(如叔丁基二甲基硅基/三苯基甲基)选择性保护伯羟基,再对仲羟基苯甲酰化,然后脱去大位阻保护基得到产品(如Tetrahedron Letters2004,1973-1976)。但这种做法也有局限性:所用试剂如叔丁基二甲基氯硅烷,三苯基氯甲烷相对较贵,且分子量较大,大幅度提高了成本;中间体不易分离提纯,杂质带到下一步;最终产品也很难结晶提纯,一般要通过柱色谱来分离纯化,使得生产周期延长,成本升高。 Another method is to use Cory lactone as a raw material to selectively introduce a benzoyl group on a secondary hydroxyl group to synthesize the target product. Cory lactone is a common intermediate, and it is easy to obtain (Tetrahedron letters1976, 4639-4642), so the preparation of benzoyl cory lactone from cory lactone is a more practical route. At present, the more typical approach is to selectively protect the primary hydroxyl group with a large steric hindrance protecting group (such as tert-butyldimethylsilyl/triphenylmethyl group), then benzoylate the secondary hydroxyl group, and then remove the Large sterically hindered protecting groups give products (eg Tetrahedron Letters 2004, 1973-1976). However, this method also has limitations: the reagents used, such as tert-butyldimethylsilyl chloride and triphenylchloromethane, are relatively expensive, and the molecular weight is relatively large, which greatly increases the cost; the intermediate is not easy to separate and purify, and the impurities are brought down One step; the final product is also difficult to crystallize and purify. Generally, it needs to be separated and purified by column chromatography, which prolongs the production cycle and increases the cost. the
发明内容: Invention content:
基于以上现状,本发明利用酸性条件下的酯交换反应,选择性的从科里内酯二苯甲酸脂科里内酯二苯甲酸酯(结构如下图所示)脱掉一个苯甲酰基,得到苯甲酰科里内酯。其中,科里内酯二苯甲酸脂科里内酯二苯甲酸酯可以很容易从科里内酯通过苯甲酰化得到,反应效果好,产品易结晶纯化。 Based on the above status quo, the present invention utilizes the transesterification reaction under acidic conditions to selectively remove a benzoyl group from coli lactone dibenzoate lipid coli lactone dibenzoate (structure shown in the figure below), Benzoyl coli lactone is obtained. Among them, coli lactone dibenzoate can be easily obtained from coli lactone through benzoylation, and the reaction effect is good, and the product is easy to crystallize and purify. the
本发明提供的苯甲酰科里内酯的制备方法,包括如下步骤(见图1): The preparation method of benzoyl coli lactone provided by the invention comprises the following steps (see Fig. 1):
(A)苯甲酰化反应:科里内酯通过苯甲酰化反应,得到科里内酯二苯甲酸酯科里内酯二苯甲酸酯; (A) Benzoylation reaction: Cory lactone undergoes a benzoylation reaction to obtain Cory lactone dibenzoate Cory lactone dibenzoate;
所述科里内酯包括(-)科里内酯及其衍生物、(+)科里内酯及其衍生物及(±)科里内酯及其衍生物。 The core lactones include (-) core lactone and its derivatives, (+) core lactone and its derivatives, and (±) core lactone and its derivatives. the
(B)酯交换反应:科里内酯二苯甲酸酯科里内酯二苯甲酸酯通过酯交换反应,脱掉一个苯甲酰基,得到苯甲酰科里内酯; (B) transesterification reaction: coli lactone dibenzoate coli lactone dibenzoate removes a benzoyl group through transesterification to obtain benzoyl coli lactone;
所述科里内酯二苯甲酸酯科里内酯二苯甲酸酯包括(-)科里内酯二苯甲酸酯、(+)科里内酯二苯甲酸酯和(±)科里内酯二苯甲酸酯; The core lactone dibenzoate core lactone dibenzoate comprises (-) core lactone dibenzoate, (+) core lactone dibenzoate and (±) Cory lactone dibenzoate;
所述苯甲酰科里内酯包括(-)苯甲酰科里内酯、(+)苯甲酰科里内酯和(±)苯甲酰科里内酯。 The benzoyl coli lactones include (-) benzoyl coli lactone, (+) benzoyl coli lactone and (±) benzoyl coli lactone. the
本发明提供的苯甲酰科里内酯的制备方法优选技术方案为: The preferred technical scheme of the preparation method of benzoyl coli lactone provided by the invention is:
(A)苯甲酰化反应:科里内酯和苯甲酰氯反应,得到科里内酯二苯甲酸酯; (A) Benzoylation reaction: coli lactone reacts with benzoyl chloride to obtain coli lactone dibenzoate;
(B)酯交换反应:在酸性条件下,科里内酯二苯甲酸酯通过酯交换反应,脱掉一个苯甲酰基,得到苯甲酰科里内酯。 (B) Transesterification reaction: Under acidic conditions, corylide dibenzoate undergoes a transesterification reaction to remove a benzoyl group to obtain benzoyl corylide. the
本发明提供的苯甲酰科里内酯的制备方法的更优选技术方案为: The more preferred technical scheme of the preparation method of benzoyl coli lactone provided by the invention is:
(A)苯甲酰化反应:在-20℃-100℃下,科里内酯和苯甲酰氯反应得到产物科里内酯二苯甲酸酯; (A) Benzoylation reaction: at -20°C-100°C, Cory lactone and benzoyl chloride react to obtain the product Cory lactone dibenzoate;
(B)酯交换反应: (B) transesterification reaction:
(a)将科里内酯二苯甲酸酯溶于溶剂S2中,在酸性条件下,在温度0-200℃反应1-100小时,蒸除溶剂S2,得科里内酯和苯甲酰科里内酯混合物; (a) Dissolve coli lactone dibenzoate in solvent S2 , react under acidic conditions at a temperature of 0-200°C for 1-100 hours, distill off solvent S2 , and obtain coli lactone and benzene Formylcolide mixture;
(b)将科里内酯和苯甲酰科里内酯混合物溶于有机溶剂S3中,水洗; (b) dissolving the mixture of coli lactone and benzoyl coli lactone in the organic solvent S3 , and washing with water;
(c)将水层蒸干回收科里内酯;有机层蒸干,用溶剂S4析晶,抽滤,得到苯甲酰科里内酯。 (c) Evaporating the water layer to dryness to recover coli lactone; evaporating the organic layer to dryness, crystallizing with solvent S4 , and suction filtering to obtain benzoyl coli lactone.
所述步骤(A)苯甲酰化反应更优选的方案为:将科里内酯与溶剂S1混合,加入碱B1和催化剂C1,在0-40℃下,滴加苯甲酰氯,滴完后0-40℃反应5-20小时;经后处理得到产物科里内酯二苯甲酸酯。 A more preferred solution for the step (A) benzoylation reaction is: mix coli lactone with solvent S 1 , add base B 1 and catalyst C 1 , add benzoyl chloride dropwise at 0-40°C, After the drop is completed, react at 0-40°C for 5-20 hours; after post-treatment, the product Cory lactone dibenzoate is obtained.
其中,科里内酯与溶剂S1的质量/体积比优选为1:1-100;最优选为1:3-10。 Wherein, the mass/volume ratio of coli lactone to solvent S 1 is preferably 1:1-100; most preferably 1:3-10.
科里内酯与碱B1、催化剂C1和苯甲酰氯的摩尔比优选为1:2-4:0-1:2-4;最优选为1:1-1.5:0-1:2-3。 The molar ratio of Cory lactone to base B 1 , catalyst C 1 and benzoyl chloride is preferably 1:2-4:0-1:2-4; most preferably 1:1-1.5:0-1:2- 3.
所述溶剂S1优选为二氯甲烷、氯仿、乙酸乙酯、四氢呋喃、1,2-二氯乙烷、乙腈、DMF和/或甲苯;最优选为二氯甲烷和/或氯仿。 The solvent S 1 is preferably dichloromethane, chloroform, ethyl acetate, tetrahydrofuran, 1,2-dichloroethane, acetonitrile, DMF and/or toluene; most preferably dichloromethane and/or chloroform.
所述碱B1优选为三乙胺、二异丙基乙胺、DBU、吡啶、氢氧化钠、氢氧化钾、氢氧化锂、碳酸钠、碳酸钾和/或碳酸铯;最优选为三乙胺和/或二异丙基乙胺。 The base B is preferably triethylamine, diisopropylethylamine, DBU, pyridine, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate and/or cesium carbonate; most preferably triethylamine amine and/or diisopropylethylamine.
所述催化剂C1优选为DMAP、DBU、2,6-二甲基吡啶和/或3,5-二甲基吡啶;是优选为DMAP。 The catalyst C 1 is preferably DMAP, DBU, 2,6-lutidine and/or 3,5-lutidine; it is preferably DMAP.
后处理方法为酸洗,碱洗,再蒸除溶剂。 The post-treatment method is pickling, alkali washing, and then distilling off the solvent. the
在步骤(B)酯交换反应中: In step (B) transesterification reaction:
所述步骤(a)更优选方案为:将科里内酯二苯甲酸酯溶于溶剂S2中,在酸性条件下,在温度50-100℃,反应10-20小时。科里内酯二苯甲酸酯在溶剂S2中的摩尔浓度优选为0.1-3mol/L;最优选为0.3-1mol/L。 A more preferred solution of the step (a) is: dissolving coli lactone dibenzoate in solvent S 2 , and reacting for 10-20 hours at a temperature of 50-100° C. under acidic conditions. The molar concentration of coli lactone dibenzoate in solvent S2 is preferably 0.1-3mol/L; most preferably 0.3-1mol/L.
所述S2优选为:叔丁醇、异丙醇、新戊醇、季戊四醇、异丁醇、正丁醇、正丙醇、乙醇、甲醇、乙二醇、甘油、PEG、苯甲醇、苯乙醇、苯丙醇、苯酚、二苯甲醇、双丙酮醇、己醇、庚醇、辛醇、壬醇、癸醇和/或十六醇中的一种或几种;最优选为叔丁醇和/或异丙醇。 The S2 is preferably: tert-butanol, isopropanol, neopentyl alcohol, pentaerythritol, isobutanol, n-butanol, n-propanol, ethanol, methanol, ethylene glycol, glycerol, PEG, benzyl alcohol, phenethyl alcohol , phenylpropanol, phenol, diphenyl alcohol, diacetone alcohol, hexanol, heptanol, octanol, nonanol, decanol and/or cetyl alcohol; most preferably tert-butanol and/or isopropanol.
所述在酸性条件下是加入硫酸、硒酸、甲基磺酸、对甲苯磺酸、三氟甲磺酸、三氧化硫、亚硫酸、二氧化硫、二氧化碳、二氧化氮、阳离子交换树脂、甲酸、苯甲酸、乙酸、苯乙酸、乙二酸、丙酸、丙烯酸、丙二酸、丁酸、丁二酸、柠檬酸、酒石酸、乳酸、丙酮酸、葡萄糖酸、苹果酸、戊酸、戊二酸、十六酸、硬脂酸、软脂酸、油酸、三氯乙酸、三氟乙酸、氢氰酸、氢氟酸、盐酸、硝酸、亚硝酸、磷酸、溴化氢、碘化氢、氯酸、高氯酸、溴酸、碘酸、高碘酸、五氧化二磷、对硝基苯酚、硼酸、氟硼酸、氟磷酸、三氟化硼、氯化铝、氯化锌、或溴化锌来实现;最优选加入硫酸、甲基磺酸。加入量优选为:在溶剂S2中的摩尔浓度为0.01-10mol/L;最优选为0.05-2mol/L。 Described under acidic condition is adding sulfuric acid, selenic acid, methanesulfonic acid, p-toluenesulfonic acid, trifluoromethanesulfonic acid, sulfur trioxide, sulfurous acid, sulfur dioxide, carbon dioxide, nitrogen dioxide, cation exchange resin, formic acid, Benzoic acid, acetic acid, phenylacetic acid, oxalic acid, propionic acid, acrylic acid, malonic acid, butyric acid, succinic acid, citric acid, tartaric acid, lactic acid, pyruvic acid, gluconic acid, malic acid, valeric acid, glutaric acid , palmitic acid, stearic acid, palmitic acid, oleic acid, trichloroacetic acid, trifluoroacetic acid, hydrocyanic acid, hydrofluoric acid, hydrochloric acid, nitric acid, nitrous acid, phosphoric acid, hydrogen bromide, hydrogen iodide, chlorine acid, perchloric acid, bromic acid, iodic acid, periodic acid, phosphorus pentoxide, p-nitrophenol, boric acid, fluoroboric acid, fluorophosphoric acid, boron trifluoride, aluminum chloride, zinc chloride, or bromide zinc; most preferably adding sulfuric acid, methanesulfonic acid. The added amount is preferably: the molar concentration in the solvent S2 is 0.01-10 mol/L; most preferably 0.05-2 mol/L.
步骤(b)中,所述有机溶剂S3优选乙酸乙酯、二氯甲烷、氯仿、1,2-二氯乙 烷、甲基叔丁基醚和/或乙醚;最优选乙酸乙酯和/或二氯甲烷。 In step (b), the organic solvent S is preferably ethyl acetate, dichloromethane, chloroform, 1,2-dichloroethane, methyl tert-butyl ether and/or diethyl ether; most preferably ethyl acetate and/or or dichloromethane.
步骤(c)中,所述溶剂S4优选为四氯化碳、甲苯、石油醚、己烷和/或乙酸乙酯;最优选为四氯化碳和/或甲苯。 In step (c), the solvent S 4 is preferably carbon tetrachloride, toluene, petroleum ether, hexane and/or ethyl acetate; most preferably carbon tetrachloride and/or toluene.
步骤(a)中的溶剂S2、步骤(b)中的有机溶剂S3及步骤(c)中的溶剂S4,三者的用量以体积比计分别为:S3:S2=1:1-10;S4:S2=1:1-10;最优选为S3:S2=1:1-5;S4:S2=1:1-5。 The solvent S 2 in the step (a), the organic solvent S 3 in the step (b) and the solvent S 4 in the step (c), the volume ratios of the three are: S 3 :S 2 =1: 1-10; S 4 :S 2 =1:1-10; most preferably S 3 :S 2 =1:1-5; S 4 :S 2 =1:1-5.
本发明首次以酸性酯交换的方式选择性脱掉双苯甲酰基化合物中的一个苯甲酰基,并应用于苯甲酰科里内酯的合成。该方法的显著优点在于完全省掉叔丁基二甲基氯硅烷、三苯基氯甲烷等较贵的保护试剂,完全用便宜的苯甲酰氯代替。由于使用单一的苯甲酰基循环保护和脱保护,所有中间体都可以反复循环利用,降低了反应的复杂性,使得合成工艺简单,后处理方便,物料利用率高,产品易纯化,易于工业化。 The invention selectively removes a benzoyl group in a bisbenzoyl compound by means of acidic transesterification for the first time, and is applied to the synthesis of benzoyl core lactone. The remarkable advantage of this method is that more expensive protective reagents such as tert-butyldimethylsilyl chloride and triphenylchloromethane are completely omitted, and are completely replaced by cheap benzoyl chloride. Due to the use of a single benzoyl cyclic protection and deprotection, all intermediates can be recycled repeatedly, reducing the complexity of the reaction, making the synthesis process simple, post-processing convenient, high material utilization rate, easy purification of products, and easy industrialization. the
附图说明:图1为制备方法流程示意图 Description of drawings: Figure 1 is a schematic flow chart of the preparation method
具体实施方式: Detailed ways:
下面结合实施例对本发明做成进一步具体说明,但本发明并不限于这些实施例。 The present invention is further specifically described below in conjunction with the examples, but the present invention is not limited to these examples. the
以下实施例选取(-)科里内脂及其衍生物,但所用方法对(+)科里内脂衍生物及(±)科里内脂衍生物同样适用(参见图1)。此方法的显著优点在于完全省掉叔 丁基二甲基氯硅烷、三苯基氯甲烷等较贵的保护基,完全用便宜的苯甲酰氯代替。由于使用单一的苯甲酰基保护和脱保护,所有中间体都可以反复循环利用,降低了反应的复杂性,显著提高了物料利用率,目标产品总收率在95%左右,纯度99.7%,ee值99.8%,远远好于其他方法(如用叔丁基二甲基氯硅烷做保护剂,产品总收率约50%;一次性得到产品纯度95%左右,需要进一步精制)。 The following examples select (-) coli lactone and its derivatives, but the method used is also applicable to (+) coli lactone derivatives and (±) coli lactone derivatives (see Figure 1). The remarkable advantage of this method is that more expensive protecting groups such as tert-butyldimethylsilyl chloride and triphenylchloromethane are completely omitted, and are completely replaced by cheap benzoyl chloride. Due to the use of a single benzoyl group for protection and deprotection, all intermediates can be recycled repeatedly, which reduces the complexity of the reaction and significantly improves the utilization rate of materials. The total yield of the target product is about 95%, and the purity is 99.7%, ee The value is 99.8%, which is far better than other methods (such as using tert-butyldimethylchlorosilane as a protective agent, the total yield of the product is about 50%; the purity of the product obtained at one time is about 95%, which needs to be further refined). the
实施例1:(-)科里内酯二苯甲酸酯制备: Embodiment 1: (-) Cory lactone dibenzoate preparation:
2000ml三口瓶中加入100g(1eq)(-)科里内脂,加入500ml二氯甲烷搅拌使其悬浮,室温下依次加入202ml(2.5eq)三乙胺和3.5g(0.05eq)DMAP,边搅拌边滴加苯甲酰氯148.5ml(2.2eq),室温搅拌20h,此时TLC监测显示已无原料。反应液用750ml1mol/L盐酸洗,分出有机相,加入500ml饱和碳酸氢钠水溶液搅拌0.5h,分出有机相,无水硫酸钠干燥,过滤,滤液蒸干得230g(-)科里内酯二苯甲酸酯,类白色固体,粗产率100%。 Add 100g (1eq) (-) coli lactone into a 2000ml three-necked flask, add 500ml dichloromethane and stir to suspend it, then add 202ml (2.5eq) triethylamine and 3.5g (0.05eq) DMAP at room temperature, while stirring 148.5ml (2.2eq) of benzoyl chloride was added dropwise, and stirred at room temperature for 20h. At this time, TLC monitoring showed that there was no raw material. The reaction solution was washed with 750ml of 1mol/L hydrochloric acid, the organic phase was separated, and 500ml of saturated aqueous sodium bicarbonate solution was added to stir for 0.5h, the organic phase was separated, dried over anhydrous sodium sulfate, filtered, and the filtrate was evaporated to dryness to obtain 230g (-) coli lactone Dibenzoate, off-white solid, crude yield 100%. the
实施例2:(-)苯甲酰科里内酯制备: Embodiment 2: (-) preparation of benzoyl core lactone:
1000ml单口瓶中加入50g(-)科里内酯二苯甲酸酯,加入500ml异丙醇和20ml1M硫酸,搅拌下加热回流24h。冷却,蒸干溶剂,溶于300ml二氯甲烷和300ml水,分出有机相,再用200ml水洗。有机相用无水硫酸钠干燥,过滤,滤液蒸干,加入100ml甲苯搅拌析晶,抽滤得到11.6g(-)苯甲酰科里内酯,产率32%,纯度99.7%,ee值99.8%。水相蒸干,溶于100ml乙酸乙酯和20ml甲醇,通过硅胶垫过滤,100ml乙酸乙酯洗涤,滤液蒸干得13g(-)科里内脂,回收率57%,可循环使用。甲苯母液蒸干,高真空度减压蒸干,所得残留物溶于异丙醇直接返回酯交换反应体系,循环使用。经过多次物料回收和循环使用,此步反应的总产率在95%左右。 Add 50g (-) coli lactone dibenzoate to a 1000ml one-mouth bottle, add 500ml isopropanol and 20ml 1M sulfuric acid, and heat to reflux for 24h while stirring. Cool, evaporate the solvent to dryness, dissolve in 300ml of dichloromethane and 300ml of water, separate the organic phase, and wash with 200ml of water. The organic phase was dried with anhydrous sodium sulfate, filtered, the filtrate was evaporated to dryness, 100ml of toluene was added to stir and crystallize, and 11.6g (-) benzoyl corylide was obtained by suction filtration, with a yield of 32%, a purity of 99.7%, and an ee value of 99.8 %. The water phase was evaporated to dryness, dissolved in 100ml ethyl acetate and 20ml methanol, filtered through a silica gel pad, washed with 100ml ethyl acetate, and the filtrate was evaporated to dryness to obtain 13g (-) coli lactone, with a recovery rate of 57%, which can be recycled. The toluene mother liquor was evaporated to dryness, then evaporated to dryness under high vacuum and reduced pressure, and the obtained residue was dissolved in isopropanol and directly returned to the transesterification reaction system for recycling. After many times of material recovery and recycling, the total yield of this step reaction is about 95%. the
实施例3:(-)科里内酯二苯甲酸酯制备: Embodiment 3: (-) Cory lactone dibenzoate preparation:
20L反应釜中加入1公斤(-)科里内脂,加入6公斤二氯甲烷搅拌使其悬浮,室温下依次加入2L三乙胺和35g DMAP,搅拌下滴加苯甲酰氯1.75公斤,反应放热温度上升,控制滴加速度使反应混合物维持缓慢回流,约3h滴完,此时TLC检识显示已无原料。反应液用8L1mol/L盐酸洗,分出有机相,无水硫酸钠干燥,过滤,滤液蒸至剩少量溶剂,加入3L甲醇搅拌析晶,抽滤,干燥得2.1公斤(-)科里内酯二苯甲酸酯,类白色粉末,产率92%,纯度98.5%。 Add 1 kg (-) Cory lactone in the 20L reactor, add 6 kg of dichloromethane and stir to make it suspended, add 2L triethylamine and 35g DMAP successively at room temperature, add 1.75 kg of benzoyl chloride dropwise under stirring, and the reaction is released. As the temperature rises, the addition rate is controlled to keep the reaction mixture under reflux slowly, and the drop is completed in about 3 hours. At this time, TLC detection shows that there is no raw material. The reaction solution was washed with 8L 1mol/L hydrochloric acid, the organic phase was separated, dried over anhydrous sodium sulfate, filtered, the filtrate was evaporated until a small amount of solvent remained, added 3L methanol, stirred and crystallized, filtered with suction, and dried to obtain 2.1 kg (-) coli lactone Dibenzoate, off-white powder, yield 92%, purity 98.5%. the
实施例4:(-)苯甲酰科里内酯制备: Embodiment 4: (-) preparation of benzoyl core lactone:
20L反应釜中加入1公斤(-)科里内酯二苯甲酸酯,加入5公斤叔丁醇和3公斤甲基磺酸和1公斤水,搅拌下加热回流10h。冷却,蒸干溶剂,溶于6L乙酸乙酯和6L水,分出有机相,再用3L水洗。有机相用无水硫酸钠干燥,过滤,滤液蒸干,加入2L四氯化炭搅拌析晶,抽滤得到0.31公斤(-)苯甲酰科里内酯,产率43%,纯度95%,ee值99%。水相蒸干,溶于2L乙酸乙酯和0.4L甲醇,通过硅胶过滤,2L乙酸乙酯淋洗,滤液蒸干得153g(-)科里内脂,回收率40%,可循环使用。四氯化碳母液蒸干,高真空度减压蒸干,所得残留物溶于叔丁醇直接返回酯交换反应体系,循环使用。经过多次物料回收和循环使用,此步反应的总产率在90%左右。 Add 1 kg of (-) Cory lactone dibenzoate to a 20L reactor, add 5 kg of tert-butanol, 3 kg of methanesulfonic acid and 1 kg of water, and heat to reflux for 10 h while stirring. Cool, evaporate the solvent to dryness, dissolve in 6L ethyl acetate and 6L water, separate the organic phase, and wash with 3L water. The organic phase was dried with anhydrous sodium sulfate, filtered, and the filtrate was evaporated to dryness, added 2L carbon tetrachloride and stirred and crystallized, and suction filtered to obtain 0.31 kg of (-) benzoyl coli lactone, with a yield of 43%, a purity of 95%, The ee value is 99%. The water phase was evaporated to dryness, dissolved in 2L ethyl acetate and 0.4L methanol, filtered through silica gel, rinsed with 2L ethyl acetate, and the filtrate was evaporated to dryness to obtain 153g (-) coli lactone, with a recovery rate of 40%, which can be recycled. The carbon tetrachloride mother liquor was evaporated to dryness, then evaporated to dryness under high vacuum and reduced pressure, and the obtained residue was dissolved in tert-butanol and directly returned to the transesterification reaction system for recycling. After several times of material recovery and recycling, the total yield of this step reaction is about 90%. the
实施例5:(+)科里内酯二苯甲酸酯制备: Embodiment 5: (+) Cory lactone dibenzoate preparation:
2000ml三口瓶中加入100g(1eq)(+)科里内脂,加入450ml二氯甲烷搅拌使其悬浮,20℃下依次加入195ml三乙胺和2g DMAP,边搅拌边滴加苯甲酰 氯150ml,约1.5h滴完,40℃搅拌4h,此时TLC监测显示已无原料。反应液用700ml1mol/L盐酸洗,分出有机相,加入500ml饱和碳酸氢钠水溶液搅拌0.5h,分出有机相,无水硫酸钠干燥,过滤,滤液蒸至剩少量溶剂,加入250ml甲醇搅拌析晶,冷却到0℃,抽滤,用少量冷的甲醇帮助转移和淋洗,干燥得215g(+)科里内酯二苯甲酸酯,类白色粉末,产率94%,纯度96%。。 Add 100g (1eq) (+) Cory lactone into a 2000ml three-necked flask, add 450ml of dichloromethane and stir to suspend it, add 195ml of triethylamine and 2g of DMAP in sequence at 20°C, and add 150ml of benzoyl chloride dropwise while stirring After about 1.5 hours, the mixture was stirred at 40° C. for 4 hours. At this time, TLC monitoring showed that there was no raw material. The reaction solution was washed with 700ml of 1mol/L hydrochloric acid, the organic phase was separated, and 500ml of saturated aqueous sodium bicarbonate solution was added to stir for 0.5h. The organic phase was separated, dried over anhydrous sodium sulfate, filtered, and the filtrate was evaporated until a small amount of solvent remained. crystallized, cooled to 0°C, suction filtered, transferred and rinsed with a small amount of cold methanol, and dried to obtain 215g (+) Cory lactone dibenzoate, an off-white powder with a yield of 94% and a purity of 96%. . the
实施例6:(+)苯甲酰科里内酯制备: Embodiment 6: (+) preparation of benzoyl core lactone:
2000ml单口瓶中加入84.8g(+)科里内酯二苯甲酸酯,加入800ml异丁醇,50g对甲苯磺酸和50ml水,搅拌下加热回流16h。冷却,蒸干溶剂,溶于500ml二氯甲烷和300ml水,分出有机相,再用300ml水洗。有机相用无水硫酸钠干燥,过滤,滤液蒸干,加入200ml甲苯搅拌析晶,抽滤得到23g(+)苯甲酰科里内酯,单循环产率37%,纯度95%。水相蒸干,溶于160ml乙酸乙酯和30ml甲醇,通过硅胶垫过滤,160ml乙酸乙酯洗涤,滤液蒸干得15.58g(+)科里内脂,用实例5的方法将此回收的(+)科里内脂制成(+)科里内酯二苯甲酸酯,与甲苯母液合并,蒸干,所得残留物用实例6上面的方法,又得到10.68g(+)苯甲酰科里内酯,所回收的10.86g(+)科里内脂与甲苯母液合并用实例5的方法将此回收的(+)科里内脂制成(+)科里内酯二苯甲酸酯,得到31.3g(+)科里内酯二苯甲酸酯,产率87%。所以经过两次物料回收和循环使用,反应实际消耗53.5g(+)科里内酯二苯甲酸酯,共得到33.86g(+)苯甲酰科里内酯,产率87%。 Add 84.8g (+) coli lactone dibenzoate to a 2000ml single-necked bottle, add 800ml isobutanol, 50g p-toluenesulfonic acid and 50ml water, and heat to reflux for 16h while stirring. Cool, evaporate the solvent to dryness, dissolve in 500ml of dichloromethane and 300ml of water, separate the organic phase, and wash with 300ml of water. The organic phase was dried with anhydrous sodium sulfate, filtered, and the filtrate was evaporated to dryness, 200ml of toluene was added to stir and crystallize, and 23g (+) benzoyl corylide was obtained by suction filtration, with a single cycle yield of 37% and a purity of 95%. The aqueous phase was evaporated to dryness, dissolved in 160ml ethyl acetate and 30ml methyl alcohol, filtered through a silica gel pad, washed with 160ml ethyl acetate, and the filtrate was evaporated to dryness to obtain 15.58g (+) coli lactone, which was reclaimed by the method of example 5 ( +) coli lactone is made into (+) coli lactone dibenzoate, merges with toluene mother liquor, evaporates to dryness, and the method for the residue obtained therefrom obtains 10.68g (+) benzoylacetate again with the method above example 6 Lilactone, the 10.86g (+) Cory lactone that reclaims and the toluene mother liquor combine and use the method for example 5 to make (+) Cory lactone dibenzoate by the (+) Cory lactone that this reclaims , Obtain 31.3g (+) core lactone dibenzoate, yield 87%. Therefore, through two times of material recovery and recycling, the reaction actually consumes 53.5g (+) coli lactone dibenzoate, and a total of 33.86g (+) benzoyl coli lactone is obtained, with a yield of 87%. the
实施例7:(±)苯甲酰科里内酯制备: Embodiment 7: (±) preparation of benzoyl core lactone:
2000ml三口瓶中加入100g(±)科里内脂,加入500ml二氯甲烷搅拌使其悬浮,室温下依次加入190ml三乙胺和2.5g DMAP,边搅拌边滴加苯甲酰氯150ml,室温搅拌20h。反应液用700ml1mol/L盐酸洗,分出有机相,无水硫酸钠 干燥,过滤,滤液蒸干得228g(±)科里内酯二苯甲酸酯,类白色固体。所得粗品固体直接加入1000ml异丙醇和40ml1M硫酸,搅拌下加热回流30h。冷却,蒸干溶剂,溶于600ml二氯甲烷和600ml水,分出有机相,再用400ml水洗。有机相用无水硫酸钠干燥,过滤,滤液蒸干,加入150ml甲苯搅拌析晶,抽滤得到25g(±)苯甲酰科里内酯,纯度99%。水相蒸干,溶于200ml乙酸乙酯和40ml甲醇,通过硅胶垫过滤,200ml乙酸乙酯洗涤,滤液蒸干得30g(±)科里内脂,可循环使用。甲苯母液蒸干,所得残留物溶于异丙醇重复酯交换操作,循环使用。 Add 100g (±) Cory lactone into a 2000ml three-necked flask, add 500ml dichloromethane and stir to suspend, add 190ml triethylamine and 2.5g DMAP in turn at room temperature, add 150ml benzoyl chloride dropwise while stirring, and stir at room temperature for 20h . The reaction solution was washed with 700ml1mol/L hydrochloric acid, the organic phase was separated, dried over anhydrous sodium sulfate, filtered, and the filtrate was evaporated to dryness to give 228g (±) coli lactone dibenzoate, off-white solid. The obtained crude solid was directly added with 1000ml of isopropanol and 40ml of 1M sulfuric acid, and heated under reflux for 30h while stirring. Cool, evaporate the solvent to dryness, dissolve in 600ml of dichloromethane and 600ml of water, separate the organic phase, and wash with 400ml of water. The organic phase was dried with anhydrous sodium sulfate, filtered, and the filtrate was evaporated to dryness, 150ml of toluene was added to stir and crystallize, and 25g (±) benzoyl corylide was obtained by suction filtration with a purity of 99%. The water phase was evaporated to dryness, dissolved in 200ml ethyl acetate and 40ml methanol, filtered through a silica gel pad, washed with 200ml ethyl acetate, and the filtrate was evaporated to dryness to obtain 30g (±) coli lactone, which can be recycled. The toluene mother liquor was evaporated to dryness, and the resulting residue was dissolved in isopropanol to repeat the transesterification operation for recycling. the
以上实施例,仅以说明为目的,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。 The above embodiments are for the purpose of illustration only, and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention should be included within the protection scope of the present invention . the
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110452240.1A CN102532079B (en) | 2011-12-29 | 2011-12-29 | Preparation method of Corey Lactone 3-benzoate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110452240.1A CN102532079B (en) | 2011-12-29 | 2011-12-29 | Preparation method of Corey Lactone 3-benzoate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102532079A CN102532079A (en) | 2012-07-04 |
CN102532079B true CN102532079B (en) | 2014-09-17 |
Family
ID=46340253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110452240.1A Expired - Fee Related CN102532079B (en) | 2011-12-29 | 2011-12-29 | Preparation method of Corey Lactone 3-benzoate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102532079B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106810411B (en) * | 2015-12-01 | 2018-09-04 | 中国科学院大连化学物理研究所 | A kind of method of acyl chlorides and 1,2- dichloroethanes reaction generation ester |
CN106810444B (en) * | 2015-12-01 | 2018-09-04 | 中国科学院大连化学物理研究所 | A kind of method of chlorobenzoyl chloride and halogenated alkane reaction generation ester |
CN106749141B (en) * | 2016-12-23 | 2019-11-12 | 东北制药集团股份有限公司 | The purification process of lactone in a kind of benzoyl section |
CN108129261A (en) * | 2017-12-29 | 2018-06-08 | 长春百纯和成医药科技有限公司 | A kind of method that lactone founds in simultaneous triphenylcarbinol processed and biphenyl -4- formyls section |
CN118955446A (en) * | 2017-12-29 | 2024-11-15 | 吉林医药学院 | A method for preparing triphenylmethanol and benzoylcorinol |
CN118994074A (en) * | 2017-12-29 | 2024-11-22 | 吉林医药学院 | Method for preparing biphenyl-4-formyl kesteride by one-pot method |
CN111646962A (en) * | 2020-06-11 | 2020-09-11 | 东北制药集团股份有限公司 | Preparation method of double-etherified substance |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0501310A1 (en) * | 1991-02-27 | 1992-09-02 | Nissan Chemical Industries Ltd. | Method for optical resolution of corey lactone diols |
US20100056808A1 (en) * | 2008-08-29 | 2010-03-04 | Alphora Research Inc. | Prostaglandin synthesis and intermediates for use therein |
CN102190642A (en) * | 2010-03-05 | 2011-09-21 | 上海天伟生物制药有限公司 | Preparation method and purification technique of dicyclic compound |
-
2011
- 2011-12-29 CN CN201110452240.1A patent/CN102532079B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0501310A1 (en) * | 1991-02-27 | 1992-09-02 | Nissan Chemical Industries Ltd. | Method for optical resolution of corey lactone diols |
US20100056808A1 (en) * | 2008-08-29 | 2010-03-04 | Alphora Research Inc. | Prostaglandin synthesis and intermediates for use therein |
CN102190642A (en) * | 2010-03-05 | 2011-09-21 | 上海天伟生物制药有限公司 | Preparation method and purification technique of dicyclic compound |
Non-Patent Citations (6)
Title |
---|
Asit K. Chakraborti,等.Influence of Hydrogen Bonding in the Activation of Nucleophiles: PhSH-(Catalytic) KF in N-Methyl-2-pyrrolidone as an Efficient Protocol for Selective Cleavage of Alkyl/Aryl Esters and Aryl Alkyl Ethers under Nonhydrolytic and Neutral Conditions.《J. Org. Chem.》.2002,第67卷(第8期),2541-2547. * |
Ian J. S. Fairlamb,等.Identification of novel mammalian squalene synthase inhibitors using a three-Dimensional pharmacophore.《Bioorganic & Medicinal Chemistry》.2002,第10卷(第8期),2641-2656. |
Ian J. S. Fairlamb,等.Identification of novel mammalian squalene synthase inhibitors using a three-Dimensional pharmacophore.《Bioorganic & * |
Medicinal Chemistry》.2002,第10卷(第8期),2641-2656. * |
Seongjin Kim,等.Silyl group deprotection by Pd/C/H2. A facile and selective method.《Tetrahedron Letters》.2004,第45卷(第9期),1973–1976. * |
吴元鎏 等.15-甲基前列腺素F2α的重要中间体——消旋4β-[3′-氧反辛烯-(1′)]-5α[苯甲酰氧]-3,3αβ,4,5,6,6αβ-六氢-2H-环戊[b]呋喃酮-(2)(Ib)的简便合成.《中国医学科学院学报》.1983,第5卷(第5期),315-318. * |
Also Published As
Publication number | Publication date |
---|---|
CN102532079A (en) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102532079B (en) | Preparation method of Corey Lactone 3-benzoate | |
CN110642897A (en) | Preparation method of beta-nicotinamide riboside chloride | |
CN102850325A (en) | Preparation method of Dabigatran etexilate key intermediate | |
CN115108904A (en) | The synthetic method of beipedox acid raw material medicine | |
CN112321589A (en) | Synthesis method of antiviral drug Reidesciclovir and intermediate thereof | |
WO2023137876A1 (en) | Method for preparing intermediate for synthesizing new deuterated cyano compound | |
CN102395591A (en) | Method for preparing prasugrel | |
CN108558692B (en) | A kind of preparation method of amide compound | |
CN107011404A (en) | A kind of method using cholic acid as Material synthesis lithocholic acid | |
CN110981779B (en) | The synthetic method of R-2-(2,5-difluorophenyl)pyrrolidine | |
CN103709221A (en) | A kind of preparation method of cordycepin | |
CN108484543B (en) | Preparation method of potassium dehydroandrographolide succinate or potassium dehydroandrographolide succinate | |
CN105061405A (en) | Preparation method of fimasartan potassium salt hydrate | |
CN110551064B (en) | Preparation method of isavuconazole sulfate and intermediate thereof | |
CN115260045A (en) | Preparation process of high-purity esmolol hydrochloride | |
CN1473832A (en) | Synthesis method of [3aS, 6aR]-1,3-dibenzyl-tetrahydro-4H-fruo [3,4-d]-imidazolyl-2,4 [1H]-diketone [I] | |
CN101348475B (en) | Novel method for synthesizing orlistat, intermediate compound and preparation thereof | |
CN109836404B (en) | Epirubicin hydrochloride intermediate compound | |
CN103626821B (en) | The synthetic method of 25-HYDROXY CHOLESTEROL | |
CN104829470B (en) | One is combined into the midbody compound of Ivabradine and its application | |
CN113004245B (en) | Preparation method of desloratadine | |
CN101987825B (en) | Method for preparing 2-amino-3-methyl-4-methoxy acetophenone | |
CN101805339A (en) | Entecavir compound prepared in novel method | |
CN115894503B (en) | A method for preparing an azacyclopentane derivative | |
CN104876872B (en) | A kind of method for preparing the methylol indazole of 1 tert-butoxycarbonyl 3 and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140917 |